← SynDRA
ML213
SynDRA canonical compound SYN1968823 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | KCNQ2 | KCNQ4 |
| Mechanism of action | potassium channel activator |
All known targets
Mechanisms of action (all sources)
- potassium channel activator
- KCNQ4 ACTIVATOR
Cross-references
Synonyms
Look up ML213 in the interactive SynDRA portal →